Clesrovimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Clesrovimab, covering 2021-04-13 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) [Phase 3]